Make Skyclarys available in Ireland!

Recent signers:
C Whelan and 19 others have signed recently.

The Issue

Imagine waking up every morning knowing that there is a treatment promising hope and better quality of life, but it is currently out of your reach. As someone living with Friedrich's Ataxia, a rare, progressive disease that impacts every facet of my life, the inaccessibility of Skyclarys in Ireland is not just a denial of medication but a barrier to a hopeful future.

Skyclarys has been clinically proven to improve muscle coordination and reduce the progression of symptoms associated with Friedrich's Ataxia. It is available in many countries globally, providing patients with an opportunity to enhance their quality of life significantly. However, here in Ireland, individuals like myself, aged 16 and over, cannot access this innovative treatment.

Statistics from the National Organization for Rare Disorders demonstrate that investing in early access to medications such as Skyclarys reduces long-term medical expenses by minimizing complications and enhancing the quality of life for patients. In Ireland, the lack of access leads to increased healthcare costs due to accelerated disease progression and the need for extensive support systems.

It's not just a matter of convenience; it's a necessity. The Irish government and healthcare authorities need to recognize the immediate need for this drug. By making Skyclarys available, they are not only providing a treatment; they are offering a lifeline that could change lives. The European Medicines Agency has already approved this drug, acknowledging its safety and efficacy. Now is the time for Ireland to follow suit.

We call upon the government and healthcare decision-makers in Ireland to prioritize access to Skyclarys for those aged 16 and over. It's time for policy change and to show compassion and support to the Friedrich's Ataxia community here in Ireland. Without access to this drug, many will continue to suffer needlessly.

Please join us in this critical cause. Sign this petition to urge the Irish healthcare system to make Skyclarys available. Your signature could be the turning point for individuals seeking better healthcare and a brighter future. Together, let's strive for change and allow every person the opportunity to live their fullest life.

 

instagram- aoifequinn31

linkedin- https://www.linkedin.com/in/aoife-quinn-b62579236?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app

10,104

Recent signers:
C Whelan and 19 others have signed recently.

The Issue

Imagine waking up every morning knowing that there is a treatment promising hope and better quality of life, but it is currently out of your reach. As someone living with Friedrich's Ataxia, a rare, progressive disease that impacts every facet of my life, the inaccessibility of Skyclarys in Ireland is not just a denial of medication but a barrier to a hopeful future.

Skyclarys has been clinically proven to improve muscle coordination and reduce the progression of symptoms associated with Friedrich's Ataxia. It is available in many countries globally, providing patients with an opportunity to enhance their quality of life significantly. However, here in Ireland, individuals like myself, aged 16 and over, cannot access this innovative treatment.

Statistics from the National Organization for Rare Disorders demonstrate that investing in early access to medications such as Skyclarys reduces long-term medical expenses by minimizing complications and enhancing the quality of life for patients. In Ireland, the lack of access leads to increased healthcare costs due to accelerated disease progression and the need for extensive support systems.

It's not just a matter of convenience; it's a necessity. The Irish government and healthcare authorities need to recognize the immediate need for this drug. By making Skyclarys available, they are not only providing a treatment; they are offering a lifeline that could change lives. The European Medicines Agency has already approved this drug, acknowledging its safety and efficacy. Now is the time for Ireland to follow suit.

We call upon the government and healthcare decision-makers in Ireland to prioritize access to Skyclarys for those aged 16 and over. It's time for policy change and to show compassion and support to the Friedrich's Ataxia community here in Ireland. Without access to this drug, many will continue to suffer needlessly.

Please join us in this critical cause. Sign this petition to urge the Irish healthcare system to make Skyclarys available. Your signature could be the turning point for individuals seeking better healthcare and a brighter future. Together, let's strive for change and allow every person the opportunity to live their fullest life.

 

instagram- aoifequinn31

linkedin- https://www.linkedin.com/in/aoife-quinn-b62579236?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app

66 people signed today

10,104


Supporter Voices

Petition updates

Share this petition

Petition created on 10 March 2026